Allarity Therapeutics, Inc. Increase (Decrease) in Other Operating Liabilities
Allarity Therapeutics, Inc. (ALLR) reported Increase (Decrease) in Other Operating Liabilities of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2024-11-14
- Allarity Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-12-31 was $0.00.
- Allarity Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-09-30 was $0.00.
- Allarity Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-06-30 was $0.00.
- Allarity Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-03-31 was -$8.00K.
- Allarity Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2023 was -$8.00K.
- Allarity Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2022 was -$99.00K.
- Allarity Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2021 was -$124.00K.
- Allarity Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2020 was -$88.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 derived: sum of 3 quarters · filed 2024-11-14 | -$8.00K 10-K · filed 2024-03-08 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | -$8.00K 10-Q · filed 2024-11-14 | -$29.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$8.00K 10-Q · filed 2024-08-05 | -$29.00K derived: sum of 3 quarters · filed 2024-08-05 | -$54.00K derived: sum of 4 quarters · filed 2024-08-05 | |
| 2023-03-31 | -$8.00K 10-Q · filed 2024-05-14 | -$29.00K derived: sum of 2 quarters · filed 2024-05-14 | -$54.00K derived: sum of 3 quarters · filed 2024-05-14 | -$84.00K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$46.00K derived: sum of 2 quarters · filed 2024-03-08 | -$76.00K derived: sum of 3 quarters · filed 2024-03-08 | -$99.00K 10-K · filed 2024-03-08 | |
| 2022-09-30 | -$25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$55.00K derived: sum of 2 quarters · filed 2023-11-14 | -$78.00K 10-Q · filed 2023-11-14 | -$104.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$53.00K 10-Q · filed 2023-08-14 | -$79.00K derived: sum of 3 quarters · filed 2023-08-14 | -$115.00K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$23.00K 10-Q · filed 2023-05-11 | -$49.00K derived: sum of 2 quarters · filed 2023-05-11 | -$85.00K derived: sum of 3 quarters · filed 2023-05-11 | -$113.00K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$62.00K derived: sum of 2 quarters · filed 2023-03-13 | -$90.00K derived: sum of 3 quarters · filed 2023-03-13 | -$124.00K 10-K · filed 2023-03-13 | |
| 2021-09-30 | -$36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$64.00K derived: sum of 2 quarters · filed 2022-11-14 | -$98.00K 10-Q · filed 2022-11-14 | -$243.00K 10-Q · filed 2021-11-23 | -$140.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-07 | -$62.00K 10-Q · filed 2022-10-07 | -$104.00K derived: sum of 3 quarters · filed 2022-10-07 | ||
| 2021-03-31 | -$34.00K 10-Q · filed 2022-05-27 | -$76.00K derived: sum of 2 quarters · filed 2022-05-27 | |||
| 2020-12-31 | -$42.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-05-17 | -$88.00K 10-K · filed 2022-05-17 | |||
| 2020-09-30 | -$46.00K 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |